HER2 is an oncogene that promotes transformation and tumor development and is overexpressed/amplified in several cancer types [158], including EOC, with reported incidence of expression ranging from 1.8% to 76% of tumors, especially in the HGSC subtype [159]. The gene discussed is ERBB2; the disease is cancer.